Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*G. Hartung, W. Queißer, Michael Gonnermann et al.|Oncology Research and Treatment|2005Cited by 64
Application of an artificial intelligence-based tool in [18F]FDG PET/CT for the assessment of bone marrow involvement in multiple myelomaChristos Sachpekidis, Antonia Dimitrakopoulou‐Strauss, Olof Enqvist et al.|European Journal of Nuclear Medicine and Molecular Imaging|2023Cited by 35
Validation of novel low-dose CT methods for quantifying bone marrow in the appendicular skeleton of patients with multiple myeloma: initial results from the [18F]FDG PET/CT sub-study of the Phase 3 GMMG-HD7 TrialChristos Sachpekidis, Antonia Dimitrakopoulou‐Strauss, Marina Hajiyianni et al.|European Journal of Nuclear Medicine and Molecular Imaging|2025Cited by 4
Interpreting [18F]FDG-avid fractures after induction therapy in multiple myeloma: insights from the PET/CT sub-study of the Phase 3 GMMG-HD7 trialChristos Sachpekidis, H Goldschmidt, Marina Hajiyianni et al.|European Journal of Nuclear Medicine and Molecular Imaging|2026Cited by 0